Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 473175, 10 pages
http://dx.doi.org/10.1155/2015/473175
Research Article

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML

Department of Hematology and Oncology, University Children’s Hospital Tübingen, University of Tübingen, Hoppe-Seyler-Straße 1, 72076 Tübingen, Germany

Received 17 December 2014; Revised 9 June 2015; Accepted 16 June 2015

Academic Editor: David Kaplan

Copyright © 2015 Patrick Schlegel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. J. L. Kaspers and U. Creutzig, “Pediatric acute myeloid leukemia: international progress and future directions,” Leukemia, vol. 19, no. 12, pp. 2025–2029, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Abrahamsson, N. Clausen, G. Gustafsson et al., “Improved outcome after relapse in children with acute myeloid leukaemia,” British Journal of Haematology, vol. 136, no. 2, pp. 229–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Rubnitz, H. Inaba, R. C. Ribeiro et al., “NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia,” Journal of Clinical Oncology, vol. 28, no. 6, pp. 955–959, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Vivier, D. H. Raulet, A. Moretta et al., “Innate or adaptive immunity? The example of natural killer cells,” Science, vol. 331, no. 6013, pp. 44–49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Pierson and J. S. Miller, “CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis,” Blood, vol. 88, no. 6, pp. 2279–2287, 1996. View at Google Scholar · View at Scopus
  6. F. Tajima, T. Kawatani, A. Endo, and H. Kawasaki, “Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia,” Leukemia, vol. 10, no. 3, pp. 478–482, 1996. View at Google Scholar · View at Scopus
  7. M. W. Lowdell, R. Craston, D. Samuel et al., “Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells,” British Journal of Haematology, vol. 117, no. 4, pp. 821–827, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Ruggeri, M. Capanni, E. Urbani et al., “Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants,” Science, vol. 295, no. 5562, pp. 2097–2100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Ruggeri, A. Mancusi, M. Capanni et al., “Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value,” Blood, vol. 110, no. 1, pp. 433–440, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Leung, “Use of NK cell activity in cure by transplant,” British Journal of Haematology, vol. 155, no. 1, pp. 14–29, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Pfeiffer, M. Schumm, T. Feuchtinger, K. Dietz, R. Handgretinger, and P. Lang, “Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia,” British Journal of Haematology, vol. 138, no. 1, pp. 97–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Feuchtinger, M. Pfeiffer, A. Pfaffle et al., “Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones,” Bone Marrow Transplantation, vol. 43, no. 11, pp. 875–881, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Lion, Y. Willemen, Z. N. Berneman, V. F. I. Van Tendeloo, and E. L. J. Smits, “Natural killer cell immune escape in acute myeloid leukemia,” Leukemia, vol. 26, no. 9, pp. 2019–2026, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Cooley, D. J. Weisdorf, L. A. Guethlein et al., “Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia,” Blood, vol. 116, no. 14, pp. 2411–2419, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. U. Michaelis, M. Mezger, M. Bornhäuser et al., “KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts,” Annals of Hematology, vol. 93, no. 9, pp. 1579–1586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Lang, K. Barbin, T. Feuchtinger et al., “Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts,” Blood, vol. 103, no. 10, pp. 3982–3985, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. G. J. L. Kaspers, M. Zimmermann, D. Reinhardt et al., “Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the international BFM study group,” Journal of Clinical Oncology, vol. 31, no. 5, pp. 599–607, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Oevermann, S. U. Michaelis, M. Mezger et al., “KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with all,” Blood, vol. 124, no. 17, pp. 2744–2747, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Velardi, L. Ruggeri, and A. Mancusi, “Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant,” Current Opinion in Hematology, vol. 19, no. 4, pp. 319–323, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Leung, R. Iyengar, V. Turner et al., “Determinants of antileukemia effects of allogeneic NK cells,” Journal of Immunology, vol. 172, no. 1, pp. 644–650, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. K. L. McQueen, K. M. Dorighi, L. A. Guethlein, R. Wong, B. Sanjanwala, and P. Parham, “Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation,” Human Immunology, vol. 68, no. 5, pp. 309–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. G. F. Torelli, N. Peragine, S. Raponi et al., “Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells,” Haematologica, vol. 99, no. 7, pp. 1248–1254, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Pende, G. M. Spaggiari, S. Marcenaro et al., “Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112),” Blood, vol. 105, no. 5, pp. 2066–2073, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. H. R. Salih, H. Antropius, F. Gieseke et al., “Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia,” Blood, vol. 102, no. 4, pp. 1389–1396, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Verheyden and C. Demanet, “NK cell receptors and their ligands in leukemia,” Leukemia, vol. 22, no. 2, pp. 249–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. M. Pfeiffer, T. Feuchtinger, H.-M. Teltschik et al., “Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children,” Haematologica, vol. 95, no. 8, pp. 1381–1388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. J. Chan, M. J. Smyth, and L. Martinet, “Molecular mechanisms of natural killer cell activation in response to cellular stress,” Cell Death and Differentiation, vol. 21, no. 1, pp. 5–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Hilpert, L. Grosse-Hovest, F. Grünebach et al., “Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses,” The Journal of Immunology, vol. 189, no. 3, pp. 1360–1371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Nowbakht, M.-C. S. Ionescu, A. Rohner et al., “Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias,” Blood, vol. 105, no. 9, pp. 3615–3622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Pfeiffer, G. Seitz, P. Ruck et al., “CD155 is involved in NK-cell mediated lysis of human hepatoblastoma in vitro,” Frontiers in Bioscience—Elite, vol. 3, no. 4, pp. 1456–1466, 2011. View at Google Scholar · View at Scopus
  31. M. M. Pfeiffer, M. Schumm, I. Müller, R. Handgretinger, and P. Lang, “IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT,” Leukemia, vol. 26, no. 11, pp. 2435–2439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Schlegel, H.-M. Teltschik, M. Pfeiffer et al., “Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children,” Best Practice and Research: Clinical Haematology, vol. 24, no. 3, pp. 443–452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Fujisaki, H. Kakuda, N. Shimasaki et al., “Expansion of highly cytotoxic human natural killer cells for cancer cell therapy,” Cancer Research, vol. 69, no. 9, pp. 4010–4017, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Peragine, G. F. Torelli, P. Mariglia et al., “Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients,” Cancer Immunology, Immunotherapy, vol. 64, no. 2, pp. 201–211, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. J. S. Miller, “Therapeutic applications: natural killer cells in the clinic,” Hematology/The Education Program of the American Society of Hematology, vol. 2013, no. 1, pp. 247–253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Pfeiffer, H. Burow, S. Schleicher, R. Handgretinger, and P. Lang, “Influence of histone deacetylase inhibitors and DNA-methyltransferase inhibitors on the NK cell-mediated lysis of pediatric B-lineage leukemia,” Frontiers in Oncology, vol. 3, article 99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. W.-H. Leung, Q. P. Vong, W. Lin, L. Janke, T. Chen, and W. Leung, “Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation,” The Journal of Experimental Medicine, vol. 210, no. 12, pp. 2675–2692, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Poggi, S. Catellani, A. Garuti, I. Pierri, M. Gobbi, and M. R. Zocchi, “Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate,” Leukemia, vol. 23, no. 4, pp. 641–648, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Diermayr, H. Himmelreich, B. Durovic et al., “NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities,” Blood, vol. 111, no. 3, pp. 1428–1436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Poggi, S. Catellani, A. Garuti, I. Pierri, M. Gobbi, and M. R. Zocchi, “Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate,” Leukemia, vol. 23, no. 4, pp. 641–648, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Diermayr, H. Himmelreich, B. Durovic et al., “NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities,” Blood, vol. 111, no. 3, pp. 1428–1436, 2008. View at Publisher · View at Google Scholar · View at Scopus